The medical community was surprised when the Food and Drug Administration (FDA) approved the higher dose of dabigatran and not the lower dose last Oct...
The new guidelines also included patients with atrial fibrillation with risk factors for stroke or blood clotting who do not have a prosthetic heart v...
People with breast implants “may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant,” according to the agency....
A recent analysis of previous data found that while warfarin and dabigatran are comparable at preventing stroke in patients with atrial fibrillation w...
The US Food and Drug Administration (FDA) has approved dabigatran etexilate (Pradaxa) to prevent strokes and thrombosis in patients with atrial fibril...
A team of researchers has uncovered the structure of a cell surface receptor, CXCR4, which guides blood and immune cell movement throughout the body. ...
Nilotinib and dasatinib, currently approved for the treatment of drug-resistant chronic myeloid leukemia (CML), provide quicker and better responses a...
The recombinant fusion protein denileukin diftitox (DD) produced a significant and durable overall response rate at 2 dose levels as compared to place...
New York, NY —Growing evidence suggests that the potent pan-deacetylase inhibitor panobinostat (LBH589) shows promising clinical activity in heavily p...
Delivering drugs in combination requires a certain balance, a balance that ensures the drugs act synergistically. And researchers say they have struck...
